PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers
CHICAGO--(BUSINESS WIRE)--Jul 31, 2019-- |!| Ludington
CHICAGO--(BUSINESS WIRE)--Jul 31, 2019-- |!| Ludington